Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-27T12:02:02.941Z Has data issue: false hasContentIssue false

The CTSA Diversity, Equity, Inclusion, and Accessibility (DEIA) Task Force’s recommendations for the CTSA program consortium

Published online by Cambridge University Press:  14 December 2022

Lori Carter-Edwards*
Affiliation:
The North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA
Maia Hightower
Affiliation:
Utah Clinical and Translational Science Institute, University of Utah, Salt Lake City, UT, USA
Vanessa Schick
Affiliation:
Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA
Tung Nguyen
Affiliation:
University of California San Francisco Clinical and Translational Science Institute, San Francisco, CA, USA
Bertha Hidalgo
Affiliation:
Center for Clinical and Translational Science, The University of Alabama at Birmingham, Birmingham, AL, USA
Lisa Cacari Stone
Affiliation:
University of New Mexico Clinical and Translational Sciences Center, Albuquerque, NM, USA
Rebecca Laird
Affiliation:
Center for Leading Innovation and Collaboration (CLIC), University of Rochester Clinical Translational Science Institute, Rochester, NY, USA
Deborah Ossip
Affiliation:
Center for Leading Innovation and Collaboration (CLIC), University of Rochester Clinical Translational Science Institute, Rochester, NY, USA
Mercedes Rubio
Affiliation:
Division of Training, Workforce Development, and Diversity, National Institute of General Medicical Sciences, National Institutes of Health, Bethesda, MD, USA
Sanae ElShourbagy Ferreira
Affiliation:
Clinical and Translational Science Awards Program Branch, National Center for Advancing Translational Science, National Institutes of Health, Bethesda, MD, USA
Olveen Carrasquillo
Affiliation:
University of Miami Clinical and Translational Science Institute, Miami, FL, USA
*
Address for correspondence: L. Carter-Edwards, PhD, The North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

The Clinical and Translational Science Award (CTSA) Program recognizes that advancing diversity, equity, inclusion, and accessibility (DEIA) requires moving beyond statements of commitment to transformative actions. In 2021, the CTSA Program created a Task Force (TF) to initiate work in support of structural and transformational initiatives that advance DEIA for the consortium and its individual hubs. We describe the process of forming the expertise-driven (DEIA) TF and our activities to date. We 1) developed and adopted the DEIA Learning Systems Framework to guide our approach; 2) defined a set of recommendations across four focus areas (Institutional; Programmatic; Community-Centered; and Social, Cultural, Environmental); and 3) designed and disseminated a survey to capture the CTSA Program’s baseline demographic, community, infrastructural, and leadership diversity. The CTSA Consortium also elevated the TF to a standing Committee to extend our understanding, development, and implementation of DEIA approaches to translational and clinical science. These initial steps provide a foundation for collectively fostering environment that support DEIA across the research continuum.

Type
Special Communications
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Association for Clinical and Translational Science

Background

The National Institutes of Health’s National Center for Advancing Translational Sciences (NIH, NCATS) highlights an environment promoting a culture to enhance workforce diversity as an essential characteristic of a successful Clinical and Translational Science Award (CTSA) Program [Reference Austin1,2]. This commitment is part of broader efforts to promote diversity and health equity across the NIH [36], the federal government [7], and throughout the medical and scientific communities [8,Reference Beard, Iruka, Laraque-Arena, Murry, Rodríguez and Taylor9]. In alignment with such efforts and with NCATS vision of bringing more treatments to all people more quickly [Reference Rutter10], NCATS also prioritized ensuring clinical trials reflect population diversity [Reference Rutter11,12].

Within the CTSA consortium, most Hubs recognize the importance of addressing diversity, equity, inclusion, and accessibility (DEIA). In a survey conducted at the CTSA Fall 2020 Program meeting (which focused on DEIA), an overwhelming majority (86%) reported being committed to making changes to improve DEIA. However, there was also recognition that despite considerable work in this area, only limited incremental progress had been made. As such, there was a call for the clinical and translational science (CTS) enterprise to move beyond statements of support to commitments toward transformative actions [Reference Carter-Edwards, Brown, Norris, Lucas-Wright and Gonzalez13]. At the meeting, four goals and several strategies for achieving DEIA within the CTSA consortium were developed. The four goals emphasized transformational leadership, parity in funding for health equity and community-oriented research, community capacity building, and diverse enrollment for clinical trials [Reference Boulware, Corbie and Aguilar-Gaxiola14]. Building on these efforts, on February 24, 2021, the CTSA Steering Committee announced that it planned to develop a DEIA Task Force (TF) to initiate the work needed to understand and advance structural DEIA efforts across the CTSA consortium. In this paper, we describe the strategic process of forming the TF, its activities, its operational framework, recommendations for structural actions, and development of an initial DEIA assessment tool.

Methods

The CTSA Steering Committee sought to form the TF by inviting all CTSA Hubs [15] within the consortium to nominate up to two representatives with expertise in DEIA for consideration in the TF. For each candidate, Hubs were required to submit a NIH biosketch resume and a 150-word maximum statement of the candidate’s expertise and interest in DEIA. A total of 55 CTSA Hubs (87%) responded to the invitation. The CTSA Program Steering Committee reviewed candidates’ biographical pages and statements and selected 14 individuals to be members of the TF, creating a representative team across racial and ethnic groups, gender, geographic regions, and areas of expertise (Table 1). Those who were not selected received an email thanking them for their willingness to serve, informing them that they would be contacted if more opportunities to be engaged with the DEIA TF work arose. The CTSA Program Steering Committee cochairs also identified and appointed two cochairs to lead the TF (Table 1).

Table 1. Members of the CTSA diversity, equity, inclusion, and accessibility (DEIA) task force

* Diversity, Equity, Inclusion, and Acessability Task Force Co-Chair.

The charge to the TF was to increase CTSA Program consortium DEIA in clinical and translational research processes and workforce development. Also emphasized was the need to go beyond common, performative DEIA efforts in addressing DEIA to more structural, transformative initiatives. Performative DEIA efforts are statements or ritual practices declaring a commitment to DEIA but they avoid addressing well-entrenched, underlying cultural and institutional barriers or the policies, resources, and actions needed to promote DEIA [Reference Kennedy16]. While performative efforts may also include providing baseline data to inform change (e.g., reporting racial/ethnic demographics of the workforce), translating these performative efforts to actual change requires implementing specific action steps to address changes in power structures and decision-making within academic institutions to support DEIA. As a result, often such performative efforts simply maintain existing power and privilege structures. In contrast, transformative DEIA efforts are those that go beyond performative actions by fostering an equitable environment that engages in ongoing activities, policies, and initiatives that are inclusive, supportive, and promote growth for often marginalized or underrepresented populations [Reference Carter-Edwards, Brown, Norris, Lucas-Wright and Gonzalez13].

At the outset, we developed three implementable short-term goals that could be accomplished during the 1-year work period related to this charge: a) develop a framework having a high-impact vision on diversity, inclusiveness, and health equity as an aim for the CTSA consortium at both a national and Hub-specific level; b) identify an initial set of recommendations for advancing DEIA within each Hub; and c) obtain a baseline understanding of where the CTSA Programs and Hubs are in addressing DEIA.

Results

The DEIA Learning System Framework (Fig. 1)

Fig. 1. CTSA DEIA Learning Health System Framework.

Through a series of monthly meetings, emails, discussions, and phone calls, we organically developed a transformational DEIA framework (Table 2). Given the complexities of DEIA, and the fact that advancing DEIA has yet to be understood collectively in CTS, the initial step in developing the framework was agreement on five guiding principles to help drive DEIA efforts. These would allow the Hubs to be centered in a standard manner for gaining a greater understanding of DEIA and to normalize approaches to be shared across the consortium. These include:

  1. 1. Accountable – Collective learning within and across Hubs must take place to advance DEIA across the CTSA consortium. Reporting to and sharing regularly with diverse stakeholders is necessary to determine individual and collective progress.

  2. 2. Feasible – Addressing DEIA strategies and tactics that can be readily defined, conducted, measured, and reported by all of the CTSA Program Hubs within a short-time frame.

  3. 3. Flexible – The ability of the CTSA Program Hubs to adapt to infrastructural changes is necessary to institutionally promote DEIA that support improvement in translational science.

  4. 4. Meaningful – Conducting DEIA strategies and tactics that are deemed important to those traditionally underrepresented in the Academy and in local communities.

  5. 5. Equitable – Fostering an environment at the CTSA Program Hubs and within the CTSA Program consortium where voices and opinions from an expanded stakeholder community are heard when designing and implementing DEIA strategies and tactics.

Table 2. Glossary of diversity, equity, inclusion, and accessibility (DEIA)

The next step in developing the framework was agreement on focus areas for the CTSA consortium, which would drive recommendations for action. Based on the goals and strategies from the Fall 2020 CTSA meeting [Reference Boulware, Corbie and Aguilar-Gaxiola14], the TF developed the following four DEIA focus areas:

  1. 1. Institutional – The CTSA Program, Hub-specific institutional policies, and within-institutional relationships.

  2. 2. Programmatic – Hub-specific training programs and initiatives.

  3. 3. Community-Centered – Interrelatedness of community engagement and efforts to end health disparities in communities of greatest need.

  4. 4. Social/Cultural/Environmental – Work environment and social spaces and situations where biases and microaggressions are embedded in day-to-day activities.

Guided by these principles and focus areas and also inspired by learning health system frameworks [8Reference Rutter11], the TF then developed the DEIA Action Cycle. This iterative component of the framework has seven stages aimed at achieving DEIA progress. The first stage is general recommendations and suggestions for addressing DEIA generated within the CTSA Hub in whatever format is deemed suitable by each Hub. The second stage is identifying objectives that the Hub intends to implement to advance its work. These should be SMART objectives (Specific, Measurable, Achievable, Relevant, Time-bound) [Reference Doran21,Reference Drucker22] and may be at multiple levels within the Hub, as well as influenced by institutional policies and procedures. Hubs should then prioritize parallel approaches balancing both short- versus long-term objectives. This entails critically reviewing what can be accomplished to demonstrate immediate progress alongside broader priorities that may require more complex infrastructural efforts. This balance is essential as focusing only on long-term priorities may miss the identification of the smaller wins through which Hubs can demonstrate rapid progress. Conversely, only focusing on short-term objectives may leave out critical longer-term strategies addressing complex infrastructural barriers.

Each Hub would then develop directed steps to meet its objectives. These steps would then be translated into actionable items including activities that can lead to recognizable outputs. Such items should also be mapped to promising practices, which eventually would be replicated and shared with other Hubs, individually and collectively. Evaluation involves assessing whether the goals and objectives were met, whether there were challenges, and identifying the lessons learned for the next iteration of recommendations and suggestions associated with the prior work conducted, thereby repeating the accountability cycle, and building on DEIA successes to create a sustainability culture. Central to each stage of the DEIA Action Cycle is that all steps need to be continuously responsive to communities and beneficiaries with input and consultation with such stakeholders at each step of the process. Whether through communication strategies, engagement, or infrastructure modifications, ensuring all activities are responsive to these vitally important stakeholders is a fundamental element of the framework.

The product of our efforts was the DEIA Learning System Framework which the TF proposes as a guide for the development of the recommendations and proposed actions by the Hubs and the consortium (Fig. 1). Regardless of the phase or readiness of the CTSA, each Hub can adopt this framework to be used at any level, whether with leadership or staff, or within the CTSA Hub and larger institution. Additionally, this DEIA learning system framework can be applicable, not only among CTSA Hubs, but also broadly across many different programs and centers.

DEIA Recommendations for CTSAs

Along with development of the framework, we also sought to identify an initial set of DEIA recommendations for each of the four focus areas. In August 2021, TF members were assigned to one of four ad hoc groups (each with 3–4 members). Each group was tasked with developing focus area-specific recommendations to help Hubs shift from performative to transformative approaches for advancing DEIA, in partnership with their affiliate institutions. To guide the small-group discussions, each ad hoc group referred to a set of four facilitating questions: 1) What focus area “ground truths” will be used to help build our DEIA framework? 2) What major concerns exist (if any) after review of the Fall 2020 CTSA Program summary report? 3) What may be missing from the recommendations?, and 4) What can be considered short- or long-term goals?

The initial recommendations by the ad hoc groups were reported to the larger TF and subsequently refined through additional input at monthly meetings and through online communications. Table 3 displays the recommendations for each of the four focus areas, including their descriptions and examples of activities for implementation. The institutional focus area includes recommendations that emphasize creating infrastructural strategies that promote meaningful opportunities for aligning DEIA program goals and leadership workforce development. The programmatic recommendations also address infrastructural change, with emphasis on DEIA capacity building through training environments for researchers and communities and more diverse, inclusive research teams.

Table 3. Diversity, equity, inclusion, and acessability task force recommendations by focus area

The community-centered recommendations, like the programmatic ones, emphasize engagement with and support for communities. There is recognition of importance of study data that are representative of the area and are inclusive of community input and demographics in conducting research. For this recommendation, CTSA Hubs are encouraged to self-define a population-based geographic area that they primarily serve. While all CTSAs are engaged in research of broad applicability and impact, this geographic area is the one each Hub intends to primarily serve with respect to the communities it engages, the outreach it performs, and research it conducts.

The social, cultural, and environmental recommendations center on actionable ways to demonstrate the value of a diverse team of researchers, staff, community members, and partnering organizations when conducting work along the research continuum. These recommendations align with those in the institutional focus area. Examples for all of these recommendations are initial ways to operationalize efforts to improve structural approaches as well as human interaction that is diverse, equitable, and inclusive.

It is also understood that each CTSA is unique in its demographic service area, mission, operations, and needs. These factors will influence how each CTSA prioritizes and implements these recommendations. In addressing these focus areas, Hubs will have different DEIA capacities and levels of readiness unique to their CTSA environment. For instance, one Hub may prioritize building its continued capacity in community-centered DEIA, whereas another may seek to target institutional DEIA efforts, and another may choose to concentrate on social-environmental and programmatic DEIA activities. This will be determined by the CTSA Hub, its parent institution, its affiliate institutions (where applicable), and its partnering community organizations. However, it is the hope that all Hubs aspire to improve DEIA in various areas and share with the consortium promising practices, challenges, and lessons learned. By doing so, we can improve our infrastructures and foster more constructive environments to collectively improve and advance CTS across the research continuum.

DEIA Survey

Our third goal was to conduct an initial DEIA assessment designed to help us identify a baseline understanding of diversity across the CTSA Program consortium and within individual Hubs and affiliated partners and collaborators. Through an iterative process among TF members, we developed a diversity survey that each Hub is being asked to complete. If there are multiple institutions within the Hub, they can provide supplemental reports. The survey includes questions to assess: 1) demographic characteristics of the community served; 2) demographic diversity (e.g., race, ethnicity, gender, disability, age) of CTSA Program Hub leadership and staff; 3) characteristics of community engagement staff and activities; 4) infrastructure to support DEIA efforts (e.g., diversity/health equity office); 5) perceived representativeness of Hub staff and leadership relative to community; and 6) existence and use of a DEIA dashboard. CTSA Hubs will be asked to save their individual-level responses for their own internal review and understanding. Individual-level data will be de-identified and only disseminated at an aggregate level and cannot be used to compare Hubs. The hope is to ultimately develop a longitudinal series of assessments to help us better understand the state of DEIA across the CTSA Hubs.

Presentations and the TF’s 1-Year Progress

The framework and recommendations were shared with the CTSA Program National Steering Committee on November 30, 2021, and May 9, 2022. Information was also disseminated to the CTSA consortium through the CTSA listservs, in the monthly consortium newsletter (“The Ansible”), through a presentation by the TF at the CTSA consortium monthly Program Webinar, and through a presentation to the Evaluation Special Interest Group on April 19, 2022, prior to the Association for Clinical and Translational Science annual meeting. On April 18, 2022, the CTSA Steering Committee elevated the DEIA from a time-limited TF to an Enterprise Committee (EC). The CTSA ECs are long-term committees that function to advance the field of translational science through ongoing open discussions, project planning, and metric assessment. The DEIA is the fifth EC of the CTSA Program. The DEIA survey was also presented to the CTSA Program Steering Committee and modified based on their feedback. It was then approved for dissemination by the CTSA Program Steering Committee and distributed to hubs on July 8, 2022. Findings of the survey will be presented at the Fall 2022 CTSA Program meeting in November 2022, and subsequently disseminated for broad use.

Summary

There is increased national recognition that our health care and public health systems must change structurally if we are serious and intentional about turning the tide on historical, disparate health outcomes [Reference Bogard, Murry and Alexander25]. The COVID-19 pandemic revealed that this reckoning must include the transformation of healthcare’s institutional infrastructures, including care delivery, education, and research, that help perpetuate systemic health inequities. These include, but are not limited to, those experienced due to race, place, ethnicity, and gender [Reference Connor, Madhavan and Mokashi26Reference Ramprasad, Qureshi, Lee and Jones29]. Central to achieving this goal are transformative efforts in support of DEIA. In this report, the CTSA DEIA EC puts forward a framework and set of recommendations for the CTSA consortium to collectively achieve our common goal of addressing DEIA. Recognizing that each Hub has unique characteristics and needs, to promote CTS that has a sustainable impact in DEIA, CTSA Hubs need to self-identify and address their own unique capacities. Also important is collaborating with the CTSA consortium to share and learn from promising practices to take collective, constructive action to improve DEIA and collectively improve how we conduct CTS. The survey findings will further inform DEIA efforts across the consortium and beyond.

Acknowledgments

The authors would like to thank the CTSA Program DEIA Task Force for their work on the recommendations by focus area, helpful discussions, and thoughtful suggestions; the CTSA Program Steering Committee and L. Ebony Boulware for their review of the manuscript and helpful discussions. They would also like to thank Michaela Butler and Melissa Trayhan from CLIC for their help in creating the image for the CTSA DEIA Learning Health System Framework.

This work was funded in part by the University of Rochester Center for Leading Innovation and Collaboration (CLIC), under Grant U24TR002260. CLIC is the coordinating center for the Clinical and Translational Science Awards (CTSA) Program, funded by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). This work was also supported in part by the NIH NCATS through Grant Award Numbers: UL1TR002489 (Carter-Edwards); UL1TR002538 (Hightower); UL1TR003167 (Schick); UL1TR001872 (Tung); 1R01HL155127–01A1 (Hidalgo); UL1TR001449 (Stone); U24TR002260 (Laird and Ossip); UL1TR002736 (Carrasquillo). This work is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, NCATS, or CLIC.

Disclosures

The authors have no conflicts of interest to declare.

References

Austin, CP. Opportunities and challenges in translational science. Clinical and Translational Science 2021; 14(5): 16291647. DOI: 10.1111/cts.13055.CrossRefGoogle ScholarPubMed
Department of Health and Human Services. PAR-21–293: Clinical and Translational Science Award (UM1 Clinical Trial Optional), 2021. (https://grants.nih.gov/grants/guide/pa-files/par-21-293.html)Google Scholar
National Insitutes of Health. Strategic Plan, 2022. (https://diversity.nih.gov/about-us/strategic-plan)Google Scholar
National Insitutes of Health. Ending Structural Racism, 2022. (https://www.nih.gov/ending-structural-racism/unite)Google Scholar
Office of Extramural Research. Request for Information (RFI): Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for Diversity, Equity, Inclusion, and Accessibility. (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-061.html)Google Scholar
The White House. Executive Order On Advancing Racial Equity and Support for Underserved Communities Through the Federal Government, 2021. (https://www.whitehouse.gov/briefing-room/presidential-actions/2021/01/20/executive-order-advancing-racial-equity-and-support-for-underserved-communities-through-the-federal-government/)Google Scholar
Association of American Medical Colleges. Addressing and Eliminating Racism at the AAMC and Beyond, 2022. (https://www.aamc.org/addressing-and-eliminating-racism-aamc-and-beyond)Google Scholar
Beard, K, Iruka, IU, Laraque-Arena, D, Murry, VM, Rodríguez, LJ, Taylor, S. Dismantling Systemic Racism and Advancing Health Equity throughout Research. NAM Perspectives. Washington, DC: Commentary, National Academy of Medicine, 2022.CrossRefGoogle Scholar
Rutter, J. The Decade Ahead: More Treatments for All People More Quickly, 2022. (https://ncats.nih.gov/director/january-2022)Google Scholar
Rutter, J. Increase Inclusivity to Improve Health for All, 2022. (https://ncats.nih.gov/director/june-2022)Google Scholar
National Center for Advancing Translational Sciences. NCATS Director Statement in Support of Ending Structural Racism and Health Disparities, 2021. (https://ncats.nih.gov/news/releases/2021/ncats-director-statement-in-support-of-ending-structural-racism-and-health-disparities)Google Scholar
Carter-Edwards, L, Brown, A, Norris, K, Lucas-Wright, A, Gonzalez, C. Advancing Collaboration and Engagement Science through a Consortium-Wide Framework for Diversity, Equity, and Inclusion. Diversity, Equity, and Inclusion – Approaches and Solutions in Translational Science. In: Conference presentation at the Fall 2020 Virtual Clinical and Translational Science Award (CTSA) Program Meeting, 2020. (https://clic-ctsa.org/events/conference/session/10026/10671)Google Scholar
Boulware, LE, Corbie, G, Aguilar-Gaxiola, S, et al. Combating structural inequities — diversity, equity, and inclusion in clinical and translational research. New England Journal of Medicine 2022; 386(3): 201203. DOI: 10.1056/NEJMp2112233.CrossRefGoogle ScholarPubMed
Funded activities under the NCATS Clinical and Translational Science Awards (CTSA). Program with NCATS’ Appropriation and Additional CTSA Funding from Other Sources, 2022. (https://ncats.nih.gov/files/CTSA-Program-Funded-Activities-and-Other-Sources_508.pdf)Google Scholar
Kennedy, D. Moving Beyond “Performative” Diversity Commitments. Presidian Blog, 2020. (https://www.presidio.edu/blog/moving-beyond-performative-diversity-commitments/)Google Scholar
Stanford, FC. The importance of diversity and inclusion in the healthcare workforce. Journal of the National Medical Association 2020; 112(3): 247249.Google ScholarPubMed
Togioka, BM, Duvivier, D, Young, E. Diversity and Discrimination In Healthcare. StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing, 2021.Google Scholar
National Center for Chronic Disease Prevention and Health Promotion. Health Equity, 2022. (https://www.cdc.gov/chronicdisease/healthequity/index.htm)Google Scholar
Rice, D. The Importance of the “A” in DEIA, 2021. (https://www.edi.nih.gov/blog/communities/importance-deia)Google Scholar
Doran, GT. There’s a S.M.A.R.T. way to write management’s goals and objectives. Management Review 1981; 70(11): 3536.Google Scholar
Drucker, PF. The Practice of Management. 1st ed. New York: Harper, 1954, pp. 404.Google Scholar
Patient-Centered Outcomes Research Insitutute. PCORI Engagement Rubric, 2016. (https://www.pcori.org/sites/default/files/Engagement-Rubric.pdf)Google Scholar
Organizing Committee for Assessing Meaningful Community Engagement in Health & Health Care Programs & Policies. Assessing meaningful community engagement: a conceptual model to advance health equity through transformed systems for health. NAM Perspectives 2022; 22(2). DOI: 10.31478/202202c.Google Scholar
Bogard, K, Murry, VM, Alexander, CM, National Academy of Medicine (U.S.). Perspectives on Health Equity and Social Determinants of Health. Washington, DC: National Academy of Medicine, pp. 2017.Google Scholar
Connor, J, Madhavan, S, Mokashi, M, et al. Health risks and outcomes that disproportionately affect women during the Covid-19 pandemic: A review. Social Science & Medicine 2020; 266: 113364.Google ScholarPubMed
Hooper, MW, Nápoles, AM, Pérez-Stable, EJ. COVID-19 and racial/ethnic disparities. JAMA 2020; 323(24): 24662467.Google Scholar
Prince, AD, Green, AR, Brown, DJ, et al. The clarion call of the COVID-19 pandemic: How medical education can mitigate racial and ethnic disparities. Academic Medicine 2021; 96(11): 1518.Google ScholarPubMed
Ramprasad, A, Qureshi, F, Lee, BR, Jones, BL. The relationship between structural racism and COVID-19 related health disparities across 10 metropolitan cities in the United States. Journal of the National Medical Association 2022; 114(3): 265273.Google ScholarPubMed
Figure 0

Table 1. Members of the CTSA diversity, equity, inclusion, and accessibility (DEIA) task force

Figure 1

Fig. 1. CTSA DEIA Learning Health System Framework.

Figure 2

Table 2. Glossary of diversity, equity, inclusion, and accessibility (DEIA)

Figure 3

Table 3. Diversity, equity, inclusion, and acessability task force recommendations by focus area